Prévisions du marché de la radio-oncologie en Asie-Pacifique jusqu\'en 2031 - Analyse régionale - par types (radiothérapie externe et radiothérapie interne) et applications (cancer du sein, cancer de la prostate, cancer du poumon, cancer de la tête et du cou, cancer du col de l\'utérus et autres)
Les initiatives stratégiques en radio-oncologie stimulent le marché de la radio-oncologie en Asie-Pacifique
La radio-oncologie recèle un potentiel énorme dans le traitement du cancer. De plus, l\'évolution constante de la radiothérapie par les acteurs du marché en termes de développement de produits, d\'innovation, de lancement de produits, d\'approbation de produits, de fusions, d\'acquisitions et de partenariats, et autres, devrait contribuer à la croissance du marché. Certaines des initiatives stratégiques récentes qui ont eu lieu sur le marché sont
- En mai 2024, Elekta a lancé son dernier accélérateur linéaire (linac), Evo, un CT-Linac avec une nouvelle imagerie haute définition améliorée par IA, capable de fournir une radiothérapie adaptative hors ligne et en ligne ainsi que des traitements de radiothérapie guidée par imagerie standard améliorés.
- En mai 2024, The Icon Group a collaboré avec Cyberknife Australia Pty Ltd pour établir jusqu\'à 6 nouvelles cliniques de radio-oncologie (joint-venture proposée), qui fourniront des traitements de radio-oncologie en utilisant le système « Cyberknife ».
- En mai 2024, GE HealthCare a lancé Revolution RT, une nouvelle solution de tomodensitométrie (TDM) de radiothérapie avec des solutions matérielles et logicielles innovantes pour aider à augmenter la précision de l\'imagerie, tout en simplifiant le flux de travail de simulation pour une expérience de parcours de soins oncologiques plus personnalisée et plus transparente pour les cliniciens et les patients.
- En avril 2024, Accuray Incorporated a présenté les avancées en matière de matériel et de logiciel conçues pour améliorer l\'expérience de traitement du cancer, à l\'ESTRO 2024. Les plateformes CyberKnife et Radixact de dernière génération fournissent aux équipes de soins médicaux la technologie nécessaire pour étendre le pouvoir curatif de la radiothérapie et répondre à l\'objectif du congrès de cette année, en comblant le fossé des soins.
- En septembre 2023, MVision AI a lancé la première solution complète de segmentation basée sur des lignes directrices (GBS) pour un contournage efficace de la radiothérapie. Guide permet aux équipes cliniques d\'évaluer avec précision les structures générées par l\'IA, leur permettant ainsi d\'affiner leurs compétences en matière de contournage. Verify permet une comparaison visuelle et volumétrique des contours, ce qui permet aux cliniques d\'observer les similitudes et les différences. La mise en œuvre combinée de Guide Verify et Contour+ englobe tous les besoins cliniques en matière de contournage de radiothérapie.
Par conséquent, les initiatives stratégiques se multiplient parmi les acteurs du marché opérant sur le marché de la radio-oncologie, qui devraient amplifier la croissance du marché et créer de nombreuses opportunités pour le marché de la radio-oncologie.
Aperçu du marché de la radio-oncologie en Asie-Pacifique
Le domaine de la radio-oncologie s\'est développé rapidement en Chine en raison d\'avancées technologiques importantes. Les coentreprises ont joué un rôle crucial dans l\'augmentation de l\'accessibilité des systèmes de radio-oncologie. Grâce à ces initiatives, les entreprises se concentrent également sur le développement de produits thérapeutiques de haute technologie. China Isotope and Radiation Corporation (CIRC) et Accuray, un développeur américain de systèmes de radiothérapie, ont créé une coentreprise en janvier 2019. Ce projet utilise les solutions de traitement de pointe et les capacités de fabrication locales d\'Accuray pour répondre aux besoins non satisfaits du marché chinois. De telles initiatives démontrent l\'engagement de la Chine à développer des compétences en radio-oncologie dans le pays, ce qui générerait des perspectives notables pour le marché de la radio-oncologie dans les années à venir.
Chiffre d\'affaires et prévisions du marché de la radio-oncologie en Asie-Pacifique jusqu\'en 2031 (en millions de dollars américains)
Segmentation du marché de la radio-oncologie en Asie-Pacifique
Le marché de la radio-oncologie en Asie-Pacifique est classé en types, applications et pays.
Sur la base des types, le marché de la radio-oncologie en Asie-Pacifique est divisé en radiothérapie externe et radiothérapie interne. Le segment de la radiothérapie externe détenait une part de marché plus importante en 2023.
En termes d\'application, le marché de la radio-oncologie en Asie-Pacifique est classé en cancer du sein, cancer de la prostate, cancer du poumon, cancer de la tête et du cou, cancer du col de l\'utérus et autres. Le segment du cancer du sein détenait la plus grande part de marché en 2023.
Par pays, le marché de la radio-oncologie en Asie-Pacifique est segmenté en Chine, Japon, Inde, Australie, Corée du Sud et reste de l\'Asie-Pacifique. La Chine a dominé la part de marché de la radio-oncologie en Asie-Pacifique en 2023.
Varian Medical Systems Inc, Elekta AB, Accuray Incorporated, IBA Worldwide (Ion Beam Applications SA), Becton Dickinson and Co, Mevion Medical Systems, NTP RADIOISOTOPES, Mallinckrodt Plc, Panacea Medical Technologies Pvt. Ltd et Curium sont quelques-unes des principales sociétés opérant sur le marché de la radio-oncologie en Asie-Pacifique.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Asia Pacific Radiation Oncology Market - Key Market Dynamics
4.1 Market Drivers:
4.1.1 Increasing Prevalence of Cancer
4.1.2 Initiatives to Support Developments in Radiation Oncology
4.2 Market Restraints
4.2.1 High Cost of Radiotherapy Equipment
4.3 Market Opportunities
4.3.1 Strategic Initiatives in Radiation Oncology
4.4 Future Trends
4.4.1 Technological Advancement in Radiation Oncology
4.5 Impact of Drivers and Restraints:
5. Radiation Oncology Market - Asia Pacific Market Analysis
5.1 Radiation Oncology Market Revenue (US$ Million), 2021-2031
6. Asia Pacific Radiation Oncology Market Analysis - by Types
6.1 External Beam Radiation Therapy
6.1.1 Overview
6.1.2 External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
6.2 Internal Beam Radiation Therapy
6.2.1 Overview
6.2.2 Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7. Asia Pacific Radiation Oncology Market Analysis - by Application
7.1 Breast Cancer
7.1.1 Overview
7.1.2 Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Prostate Cancer
7.2.1 Overview
7.2.2 Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Lung Cancer
7.3.1 Overview
7.3.2 Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Head and Neck Cancer
7.4.1 Overview
7.4.2 Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Cervical Cancer
7.5.1 Overview
7.5.2 Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8. Asia Pacific Radiation Oncology Market - Country Analysis
8.1 Asia Pacific
8.1.1 Asia Pacific: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
8.1.1.1 China: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.1.1 China: Radiation Oncology Market Breakdown, by Types
8.1.1.1.2 China: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.1.3 China: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.1.4 China: Radiation Oncology Market Breakdown, by Application
8.1.1.2 Japan: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.2.1 Japan: Radiation Oncology Market Breakdown, by Types
8.1.1.2.2 Japan: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.2.3 Japan: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.2.4 Japan: Radiation Oncology Market Breakdown, by Application
8.1.1.3 India: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.3.1 India: Radiation Oncology Market Breakdown, by Types
8.1.1.3.2 India: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.3.3 India: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.3.4 India: Radiation Oncology Market Breakdown, by Application
8.1.1.4 Australia: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.4.1 Australia: Radiation Oncology Market Breakdown, by Types
8.1.1.4.2 Australia: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.4.3 Australia: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.4.4 Australia: Radiation Oncology Market Breakdown, by Application
8.1.1.5 South Korea: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.5.1 South Korea: Radiation Oncology Market Breakdown, by Types
8.1.1.5.2 South Korea: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.5.3 South Korea: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.5.4 South Korea: Radiation Oncology Market Breakdown, by Application
8.1.1.6 Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.1.1.6.1 Rest of APAC: Radiation Oncology Market Breakdown, by Types
8.1.1.6.2 Rest of APAC: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
8.1.1.6.3 Rest of APAC: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
8.1.1.6.4 Rest of APAC: Radiation Oncology Market Breakdown, by Application
9. Radiation Oncology Market - Industry Landscape
9.1 Overview
9.2 Growth Strategies in Radiation Oncology Market
9.3 Organic Growth Strategies
9.3.1 Overview
9.4 Inorganic Growth Strategies
9.4.1 Overview
10. Company Profiles
10.1 Varian Medical Systems Inc
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview (Siemens Healthineers AG)
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Elekta AB
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Accuray Incorporated
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 IBA Worldwide (Ion Beam Applications SA)
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Becton Dickinson and Co
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Mevion Medical Systems
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 NTP RADIOISOTOPES
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Mallinckrodt Plc
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Panacea Medical Technologies Pvt. Ltd
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Curium
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
List of Tables
Table 1. Asia Pacific Radiation Oncology Market Segmentation
Table 2. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 3. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 4. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 5. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 6. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 7. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 8. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 9. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 10. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 11. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 12. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 13. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 14. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 15. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 16. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 17. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 18. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 19. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 20. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 21. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 22. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 23. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 24. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 25. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 26. Recent Organic Growth Strategies in Radiation Oncology Market
Table 27. Recent Inorganic Growth Strategies in the Radiation Oncology Market
Table 28. Glossary of Terms, Radiation Oncology Market
List of Figures
Figure 1. Asia Pacific Radiation Oncology Market Segmentation, by Country
Figure 2. Radiation Oncology Market - Key Market Dynamics
Figure 3. Statistics at Glance, Global, 2022
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Radiation Oncology Market Revenue (US$ Million), 2021-2031
Figure 6. Radiation Oncology Market Share (%) - by Types (2023 and 2031)
Figure 7. External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Radiation Oncology Market Share (%) - by Application (2023 and 2031)
Figure 10. Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Asia Pacific Radiation Oncology Market, by Key Countries - Revenue (2023) (US$ Million)
Figure 17. Asia Pacific: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 18. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 19. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 20. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 21. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 22. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 23. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 24. Growth Strategies in Radiation Oncology Market
- Varian Medical Systems Inc.
- Elekta AB.
- Accuray Incorporated.
- IBA Worldwide (Ion Beam Applications SA).
- Becton Dickinson and Co.
- Mevion Medical Systems.
- NTP RADIOISOTOPES.
- Mallinckrodt Plc.
- Panacea Medical Technologies Pvt. Ltd
- Curium.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific radiation oncology market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific radiation oncology market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific radiation oncology market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.